论文信息 - An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies - 字舞流文

An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies

E. Compérat | P. Boelle | Y. Chrétien | J. Gligorov | J. Lotz | D. Brault | Alexandre Perrier | G. Lefèvre | M. Boissan | A. Perrier